WHO ICTRP trial
Study of the use of dexmedetomidine for cystoscopy, hysteroscopy and transrectal…
ACTRN12610000499088 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12610000499088 |
|---|---|
| Public title | Study of the use of dexmedetomidine for cystoscopy, hysteroscopy and transrectal ultrasound guided biopsy of the prostate (TRUS biopsy) |
| Scientific title | Study of the tolerability and effectiveness for surgeons and patients of the use of dexmedetomidine for cystoscopy, hysteroscopy and transrectal ultrasound guided biopsy of the prostate (TRUS biopsy). |
| Primary sponsor | Michael Keane |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 / Phase 4 |
| Countries | Australia |
| Conditions | Anaesthesia for cystoscopy, hysteroscopy and TRUS biopsy; Anaesthesia for cystoscopy, hysteroscopy and TRUS biopsy;Anaesthesiology - Anaesthetics |
| Interventions | Patients who require cystoscopy, hysteroscopy or TRUS biopsy will be given an anaesthetic regimen based on dexmedetomidine. The procedures will be a one off. Dexmedetomidine will be given intravenously (IV). Patients will receive a loading… |
| Registration date | Jun 17, 2010 |
| Target size | 45 |
| Secondary IDs | nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: